Navigation Links
Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
Date:5/21/2013

New York, NY (PRWEB) May 21, 2013

Two-thirds of patients who have been diagnosed with leukemia, melanoma or non-small cell lung cancer reported that they engage in at least one type of non-adherent behavior in their medicine use, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The research will be presented today at the 18th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in New Orleans.

“Cancer treatment is rapidly evolving with the emergence of highly effective oral targeted therapies, which has increased the importance of patients being adherent with their medications,” said Marco DiBonaventura, Ph.D., vice president, health outcomes, with Kantar Health. “When looking at adherence from a patient’s perspective among those with a type of cancer where oral therapies are the standard of care, we found that a significant number engaged in some type of non-adherent behavior—such as forgetting to take their medicine or not taking their medication as directed—which resulted in worse outcomes and higher healthcare resource use.”

Cancer patients who were non-adherent had significantly worse mental health status, and tended to have been hospitalized and visited the emergency room more often than adherent patients.

“The results of our survey suggest that non-adherence among these cancer patients may result in mental health impairments and possibly greater resource use,” DiBonaventura said. “As more oral targeted therapies emerge in oncology, pharma companies should emphasize improving adherence rates to maximize the benefits of these treatments for patients and to reduce societal costs.”

Visit Kantar Health’s website to download the full poster, “Adherence and Its Association with Health Outcomes among Patients Currently Treated for Leukemia, Melanoma or Non-Small Cell Lung Cancer (NSCLC).”

About the National Health and Wellness Survey (NHWS)

The study’s results were drawn from the 2012 U.S. NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.

Kantar Health conducts the NHWS in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported dataset in the healthcare industry.

About Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10743490.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Three Kids Dead From Codeine After Surgery: FDA
2. Symposium on sustainability to feature three new NJIT faculty
3. Three Penn State research pioneers among first Golden Goose honorees
4. Renowned Pittsburgh Plastic Surgeon to Be Keynote Speaker at Three Prestigious Conferences
5. Garden Media Group Adds Three New Clients
6. Three Certifications Are Now Available Online in the Exciting Field of EKG and Telemetry
7. Maui Wowi Rings in the New Year With Three New Florida Locations to Open in 2013
8. Three Surgeons of Los Angeles Colon and Rectal Surgical Associates Have Received the Prestigious 2013 Los Angeles SuperDoctors Award for the Second Year in a Row
9. MotoSport Announces the Ultimate Ride Giveaway with up to $20,000 in Prizes and Three Ways to Win
10. Three Dentists Awarded Master Dental Sleep Physician Designation at Elite Dental Institute’s Annual Collaborative Sleep Symposium
11. Three Leading Telecommunications and Technology Organizations Sponsor the AG Bell Listening and Spoken Language Knowledge Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: